Literature DB >> 2168411

Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors.

D A Jans1, B A van Oost, H H Ropers, F Fahrenholz.   

Abstract

The gene responsible for familial vasopressin-resistant nephrogenic diabetes insipidus (NDI) has been localized to a small region of the human X-chromosome (Xq28). A series of hamster lung fibroblast and mouse lymphocyte cell lines carrying fragments of the wild type human X-chromosome was analyzed for vasopressin renal-type V2 receptor expression, to test the hypothesis that the NDI locus may have identity with the V2 receptor gene. V2 receptor binding activity and induction of cAMP production in response to [Arg8] vasopressin (AVP) were exhibited by all cell lines carrying the wild type NDI locus, in contrast to control cell lines. AVP stimulation of cAMP production was concentration-dependent and could be almost completely inhibited by co-incubation with a V2-V1 receptor-specific antagonist. The V2-specific agonist [Mpa1,Val4,Sar7]AVP was as potent as AVP in inducing cAMP production by NDI-DNA-carrying cells, whereas no response was shown to other hormones such as calcitonin, oxytocin (less than 10(-8) M), isoproterenol, or an oxytocin-specific agonist. All results were consistent with the hypothesis that the V2 receptor gene co-localized with the NDI locus, supporting the view that the loci are one and the same.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168411

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.

Authors:  Akira Ashida; Daisuke Yamamoto; Hyogo Nakakura; Hideki Matsumura; Shinichi Uchida; Sei Sasaki; Hiroshi Tamai
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

2.  X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

Authors:  D G Bichet; M F Arthus; M Lonergan; G N Hendy; A J Paradis; T M Fujiwara; K Morgan; M C Gregory; W Rosenthal; A Didwania
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

3.  X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.

Authors:  D G Bichet; G N Hendy; M Lonergan; M F Arthus; S Ligier; Z Pausova; R Kluge; H Zingg; P Saenger; E Oppenheimer
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

Review 4.  Nephrogenic diabetes insipidus: identification of the genetic defect.

Authors:  N Knoers; A van den Ouweland; J Dreesen; M Verdijk; L A Monnens; B A van Oost
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.

Authors:  N Knoers; P M Janssens; J Goertz; L A Monnens
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

Review 6.  Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.

Authors:  N Knoers; L A Monnens
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

7.  Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus.

Authors:  R S Wildin; M J Antush; R L Bennett; J M Schoof; C R Scott
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

8.  Structure and chromosomal localization of the human antidiuretic hormone receptor gene.

Authors:  A Seibold; P Brabet; W Rosenthal; M Birnbaumer
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

9.  Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.

Authors:  H Tsukaguchi; H Matsubara; S Taketani; Y Mori; T Seido; M Inada
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.